(324 days)
Not Found
No
The description details a device that uses infrared light absorption and a polarographic oxygen cell for gas measurement, processed by analog and digital circuits with proprietary software algorithms. There is no mention of AI or ML techniques.
No
The device is a patient monitor designed to measure and display concentrations of anesthetic gases and other patient gases, which is a diagnostic function, not a therapeutic one.
Yes
The device monitors the concentrations of anesthetic gases and other patient gases in the breathing circuit, which provides information to medical professionals that aids in the assessment of the patient's physiological state and the effects of anesthesia.
No
The device description clearly outlines multiple hardware components including a power supply, pneumatic system, measurement sample cell, optical bench assembly, infrared light source, optical detector, optical filters, polarographic oxygen cell, analog circuit board, and digital circuit board. While software is mentioned as a major functional subsystem, it is integrated with and dependent on these hardware components for its function.
Based on the provided text, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- Intended Use: The intended use clearly states that the device is for "monitoring concentrations of anesthetic gases" and "end-tidal carbon dioxide, nitrous oxide and Additionally, this more and to monitor these anesthetic agents is most commonly encountered in the operating room during administration of anesthesia." This involves monitoring gases directly from the patient's breathing circuit, which is a direct physiological measurement, not an analysis of a sample taken from the body (like blood, urine, or tissue).
- Device Description: The description details how the device draws a continuous flow of sample gas from the patient's breathing circuit and analyzes it using infrared light absorption and a polarographic oxygen cell. This is consistent with a patient monitoring device that measures gases in real-time from the patient's respiratory system.
- Lack of IVD Characteristics: The description does not mention analyzing biological samples (blood, urine, etc.) or performing tests on samples outside the body to diagnose a condition or determine the state of health.
IVDs are typically used to examine specimens derived from the human body to provide information for the diagnosis, prevention, monitoring, treatment, or alleviation of disease. This device is monitoring gases directly from the patient's respiratory system during anesthesia administration, which falls under the category of physiological monitoring.
N/A
Intended Use / Indications for Use
The Invivo Research Inc. Millennia 3500 Series Monitor with Anesthetic Agent monitoring is intended for general hospital or clinical use by medical professionals whenever it is required to monitor concentrations of anesthetic gases. The agents monitored include halothane, enflurane, isoflurane, sevoflurane and desflurane. Additionally, this monitor also monitors end-tidal carbon dioxide, nitrous oxide and oxygen gas concentrations. The need to monitor these anesthetic agents is most commonly encountered in the operating room during administration of anesthesia. This device is available for sale only upon the order of a physician or other related licensed medical professional.
Product codes (comma separated list FDA assigned to the subject device)
73 CFR/21CFR 868.1500 Class II, 73 CFR/21CFR 868.1620 Class II, 73 CFR/21CFR 868.1720 Class II, 74 DRT
Device Description
The Millennia 3500 Series Monitor with Anesthetic Agents Monitor is a patient monitor which draws a continuous flow of sample gas from the patient's anesthesia breathing circuit. The sample is then drawn through a measurement sample cell where the agent(s) and other patient gas concentrations are measured. Measured values are displayed as numbers and waveforms on the main display of the monitor. The monitor is operated by controls on the front panel of the monitor. The major functional subsystems of the device are the power supply, the pneumatic system, the measurement sample cell, the system electronics and product software. Power is supplied by an AC power cord, or an internal set of batteries. AC power is internally conditioned by the power supply subassembly, which powers the system and charges the internal batteries. The pneumatic system draws sample gas into the device through a moisture collection system. The sample then enters the sample cell, which is a cavity within the optical bench assembly. The sample is then exhausted out the rear of the unit. The sample cell cavity allows infrared light to be passed through the sample so a detector on the other side of the sample can measure the amount of infrared light absorption. The infrared light source consists of a resistive element which radiates a relatively wide spectrum of infrared light. The amount of transmitted infrared light is measured by an optical detector, and several optical filters are used to determine the identity and concentration of the anesthetic agents, nitrous oxide and carbon dioxide. The oxygen measurements are obtained using a polarographic oxygen cell which also receives sample gas from the sample cell. The electronic system consists of an analog circuit board, and a digital circuit board. These boards are added to the existing standard Millennia 3500 Series Patient Monitoring System. The analog board takes the electrical signals from the sample cell assembly and conditions them so that measurement calculations can be performed. The digital circuit board digitizes the conditioned analog signals and performs measurement calculations. Proprietary software algorithms are used to calculate measured concentrations of anesthetic agents and patient gases in the sample gas.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
medical professionals / general hospital or clinical use, operating room during administration of anesthesia
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
The Invivo Research Inc. Millennia 3500 Series Monitor with Anesthetic Agent monitor conforms with national and available international product safety standards for electrical, electromagnetic compatibility, and anesthetic agent monitoring.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
K832113, K903104, K923276, K932098, K883254, K903104, K892646, K942737
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 870.2300 Cardiac monitor (including cardiotachometer and rate alarm).
(a)
Identification. A cardiac monitor (including cardiotachometer and rate alarm) is a device used to measure the heart rate from an analog signal produced by an electrocardiograph, vectorcardiograph, or blood pressure monitor. This device may sound an alarm when the heart rate falls outside preset upper and lower limits.(b)
Classification. Class II (performance standards).
0
OCT 28 1998
510(k) Summary of Safety and Effectiveness
Submitter Information:
Invivo Research Inc. 12601 Research Parkway Orlando, FL 32826 407-275-3220 Contact: Mr. Francis Casey
Product Name:
| Proprietary: | Millennia 3500 Series Monitor with Anesthetic Agent Monitoring |
|---|---|
| Common: | Anesthetic Gas Analyzer |
| Classification: | Anesthetic Gas Analyzer, enflurane - (73 CFR/21CFR 868.1500 Class II) |
| Anesthetic Gas Analyzer, halothane - (73 CFR/21CFR 868.1620 Class II) | |
| Oxygen Gas Analyzer - (73 CFR/21CFR 868.1720 Class II) |
Predicate Devices:
The predicate device(s) are the Datex AS/3 Anesthesia Agent Monitor (510(k) numbers K832113, K903104, K923276, K932098), the Datascope Multinex Anesthetic Agent Monitor (510(k) numbers K883254, K903104), and the Criticare Poet II Anesthesia Agent Monitor (510(k) numbers K892646, K942737). These predicate devices have the same performance specifications as the Millennia 3500 Series Monitor with Anesthetic Agents Monitor.
Device Description:
The Millennia 3500 Series Monitor with Anesthetic Agents Monitor is a patient monitor which draws a continuous flow of sample gas from the patient's anesthesia breathing circuit. The sample is then drawn through a measurement sample cell where the agent(s) and other patient gas concentrations are measured. Measured values are displayed as numbers and waveforms on the main display of the monitor. The monitor is operated by controls on the front panel of the monitor. The major functional subsystems of the device are the power supply, the pneumatic system, the measurement sample cell, the system electronics and product software. Power is supplied by an AC power cord, or an internal set of batteries. AC power is internally conditioned by the power supply subassembly, which powers the system and charges the internal batteries. The pneumatic system draws sample gas into the device through a moisture collection system. The sample then enters the sample cell, which is a cavity within the optical bench assembly. The sample is then exhausted out the rear of the unit. The sample cell cavity allows infrared light to be passed through the sample so a detector on the other side of the sample can measure the amount of infrared light absorption. The infrared light source consists of a resistive
1
element which radiates a relatively wide spectrum of infrared light. The amount of transmitted infrared light is measured by an optical detector, and several optical filters are used to determine the identity and concentration of the anesthetic agents, nitrous oxide and carbon dioxide. The oxygen measurements are obtained using a polarographic oxygen cell which also receives sample gas from the sample cell. The electronic system consists of an analog circuit board, and a digital circuit board. These boards are added to the existing standard Millennia 3500 Series Patient Monitoring System. The analog board takes the electrical signals from the sample cell assembly and conditions them so that measurement calculations can be performed. The digital circuit board digitizes the conditioned analog signals and performs measurement calculations. Proprietary software algorithms are used to calculate measured concentrations of anesthetic agents and patient gases in the sample gas.
Intended Uses:
The Invivo Research Inc. Millennia 3500 Series Monitor with Anesthetic Agent monitoring is intended for general hospital or clinical use by medical professionals whenever it is required to monitor concentrations of anesthetic gases. The agents monitored include halothane, enflurane, isoflurane, sevoflurane and desflurane. Additionally, this monitor also monitors end-tidal carbon dioxide, nitrous oxide and oxygen gas concentrations. The need to monitor these anesthetic agents is most commonly encountered in the operating room during administration of anesthesia. This device is available for sale only upon the order of a physician or other related licensed medical professional.
Technological Comparison to Predicate Device(s):
The Invivo Research Inc. Millennia 3500 Series Monitor with Anesthetic Agent monitor uses a polychromatic non-dispersive infrared light (NDIR) system to identify and measure the anesthetic gases and carbon dioxide. This technology is identical to the other cited predicate devices listed above.
Summary of Performance Testing:
The Invivo Research Inc. Millennia 3500 Series Monitor with Anesthetic Agent monitor conforms with national and available international product safety standards for electrical, electromagnetic compatibility, and anesthetic agent monitoring.
2
Image /page/2/Picture/1 description: The image shows the seal of the U.S. Department of Health and Human Services. The seal features a stylized caduceus, a symbol often associated with medicine and healthcare, consisting of a staff with two snakes coiled around it. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the caduceus.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 28 1998
Mr. Francis X. Casey Invivo Research, Inc. 12601 Research Parkway Orlando, FL 32826
Re : K974581 Millennia 3500 Series Patient Monitor with Anesthetic Agent Regulatory Class: II (two) Product Code: 74 DRT Dated: August 3, 1998 Received: August 4, 1998
Dear Mr. Casey:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions aqainst misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General requlation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in requlatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
3
Page 2 - Mr. Francis X. Casey
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labelinq requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597, or at its internet address "http://www.fda.qov/cdrh/dsma/dsmamain.html".
Sincerely yours,
Thomas J. Callahan
Thomas J. Callahan, Ph.D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Intended Uses
The Invivo Research Inc. Millennia 3500 Series Monitor with Anesthetic Agent monitoring is intended for general hospital or clinical use by medical professionals whenever it is required to monitor concentrations of anesthetic gases. The agents whonitored include halothane, enflurane, isoflurane, sevoflurane and desflurane. Additionally, this monitor also monitors end-tidal carbon dioxide, nitrous oxide and Additionally, this more and to monitor these anesthetic agents is most commonly encountered in the operating room during administration of anesthesia. This device is available for sale only upon the order of a physician or other related licensed medical professional.
Kramer
(Division Sign-Division of Care and Neurologic 510(k) Num
prescriptions use ✓